Propanc Biopharma, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Propanc Biopharma, Inc. reported Cash And Cash Equivalents At Carrying Value of $4.1 thousand for the year ending 2022.

  • Propanc Biopharma, Inc. showed an increase of +80.4% in Cash And Cash Equivalents At Carrying Value from 2021 to 2022.
  • This data is from Propanc Biopharma, Inc.'s annual report (Form 10-K), filed with the SEC on September 28, 2022.
  • XBRL data for this metric is available from 2011 to 2022 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2011 to 2022), Propanc Biopharma, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 2,981.1%.
  • Historical annual values: Fiscal year 2022: $4.1 thousand | Fiscal year 2021: $2.3 thousand | Fiscal year 2020: $67.0 thousand | Fiscal year 2014: $87.8 thousand | Fiscal year 2013: $0.00 | Fiscal year 2012: $179.00 | Fiscal year 2011: $132.00.
  • Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: